HILLEVAX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.1 USD | +15.00% |
|
+12.02% | -5.92% |
| May. 09 | HilleVax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 05 | Hillevax Insider Sold Shares Worth $264,467, According to a Recent SEC Filing | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 623M | - | - | - | - | - | |
| 49.18B | - | |||||
| 42.11B | ||||||
| 40.37B | ||||||
| 28.85B | ||||||
| 26.09B |
- Stock Market
- Equities
- HLVX Stock
- Charts HilleVax, Inc.
- Sector Chart